Online inquiry

IVTScrip™ mRNA-Human ARHGAP25, (Cap 1, Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK25290MR)

This product GTTS-WK25290MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & Pseudo-UTP. It ecodes the ARHGAP25 protein. This product can be used in Effector CD8+ memory T (Tem) cell-related researches.
Specifications
Product type mRNA
Modified bases Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001007231.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 9938
UniProt ID P42331
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGAP25, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK25290MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK17622MR IVTScrip™ mRNA-Human ANKRD36BP2, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANKRD36BP2
GTTS-WK27803MR IVTScrip™ mRNA-Human ASCC2, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ASCC2
GTTS-WK18390MR IVTScrip™ mRNA-Human Albumin, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Albumin
GTTS-WK8900MR IVTScrip™ mRNA-Human ADAMTS16, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADAMTS16
GTTS-WK16109MR IVTScrip™ mRNA-Human ANKRD20A8P, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD20A8P
GTTS-WK26876MR IVTScrip™ mRNA-Human ARRB2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARRB2
GTTS-WK25998MR IVTScrip™ mRNA-Human ASB2, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ASB2
GTTS-WK25099MR IVTScrip™ mRNA-Human ASB7, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ASB7
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →